about
An update on antibody-based immunotherapies for Clostridium difficile infectionPosttranslational Modifications and the Immunogenicity of BiotherapeuticsSelection and characterization of high affinity VEGFR1 antibodies from a novel human binary code scFv phage library.Fully Human VH Single Domains That Rival the Stability and Cleft Recognition of Camelid AntibodiesStructural hot spots for the solubility of globular proteins.Molecular Imaging of Pancreatic Cancer with Antibodies.Antibody H3 Structure Prediction.Structural reconstruction of protein ancestry.Engineered Fc based antibody domains and fragments as novel scaffolds.Increased Fab thermoresistance via VH-targeted directed evolution.Inhibition of preS1-hepatocyte interaction by an array of recombinant human antibodies from naturally recovered individuals.Discovery of high affinity anti-ricin antibodies by B cell receptor sequencing and by yeast display of combinatorial VH:VL libraries from immunized animals.Engineered Autonomous Human Variable DomainsThe Intrinsic Dynamics and Unfolding Process of an Antibody Fab Fragment Revealed by Elastic Network ModelDelineation of autoantibody repertoire through differential proteogenomics in hepatitis C virus-induced cryoglobulinemia.Circumventing the stability-function trade-off in an engineered FN3 domainMultivalent pIX phage display selects for distinct and improved antibody properties.Accelerated formulation development of monoclonal antibodies (mAbs) and mAb-based modalities: review of methods and tools.A multiscale view of therapeutic protein aggregation: a colloid science perspective.Monoclonal antibodies: technologies for early discovery and engineering.Enhancing Stability of Camelid and Shark Single Domain Antibodies: An Overview.Molecular dynamics simulations and docking enable to explore the biophysical factors controlling the yields of engineered nanobodies.Therapeutic anti-IgE monoclonal antibody single chain variable fragment (scFv) safety and immunomodulatory effects after one time injection in four dogs.How B-Cell Receptor Repertoire Sequencing Can Be Enriched with Structural Antibody Data.PON-SC - program for identifying steric clashes caused by amino acid substitutions.Comparison of Tobacco Host Cell Protein Removal Methods by Blanching Intact Plants or by Heat Treatment of Extracts.Overcoming low yields of plant-made antibodies by a protein engineering approach.Engineering of a peptide probe for β-amyloid aggregates.Bispecific antibodies with native chain structure.Modification of the kinetic stability of immunoglobulin G by solvent additives
P2860
Q26740788-9FB662DB-3464-4564-9379-45CE64C6BD76Q26748614-705607D7-A2F0-4A50-AF9A-E47B5A72D816Q27330448-645C6184-F163-424A-A6A2-F6C5A30BE3EAQ30372369-DD56AA98-D2C6-422B-B035-29F9433F2220Q30384777-95B19F7D-58F5-49BE-8D85-9BF0D3C19A95Q30393523-6D18A28B-C3A4-44D1-83AA-F7BB7762B296Q30398990-761B6D49-2576-4EA8-9189-20BE27C96667Q30400464-52E89B38-7D16-4882-B511-363166CABBD2Q34289289-C5B589D3-357F-41B8-A615-F7BFCF400889Q35748485-7CC50821-A320-4B74-98CA-B86E8CB77C30Q35926878-86D073F0-53CE-40EB-B368-DB67A26E79F8Q36029366-9B8F92C1-B63D-42FC-9939-9AA1338FC01EQ36140177-90A4C068-0D9E-4604-9AFB-A30659433558Q36404277-A20EC70F-2C15-42B7-A96C-793DDE7EA903Q37086915-A593FC44-C861-4B11-B50F-3230BD988663Q37367962-1BC59878-EA8B-4841-B58F-E560FDB12661Q37501464-A5D8EFB8-261F-429A-9D2C-BAA66E6F0B49Q38313350-9EC75AB2-ABCF-4CC5-9D78-EE4425988AC8Q38378651-46EECB0F-8BCF-4000-BAA9-45EDEC294847Q38633596-92549F4E-0074-45D3-A3DF-D867909AEDFDQ41108385-2D59B7AA-B882-45E7-B892-38B636027251Q41382042-2E4AD9B4-B3F0-471E-9883-D31F9F43ADA8Q44865598-00F5627A-CE7A-4E03-A02F-2FE3D4B13D00Q47113886-BD302856-5282-411C-9DF5-96D9C7F939C6Q47351054-73DCB55E-F18D-4019-9EC3-8AFE99129FE8Q49073589-F804878B-AC36-472E-98E2-F053F237FEB7Q50905901-8A298C7D-3830-4980-B8B0-4F433B86B505Q53208723-F6BC84F4-BD39-43DD-BAED-F9B418F1F457Q54378647-6EAFB121-21F3-49A8-84F4-781CBF612EDFQ57839816-6E7D7BEF-1E1A-4828-BF75-DA6E903E8A7C
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Stability engineering of the human antibody repertoire
@ast
Stability engineering of the human antibody repertoire
@en
Stability engineering of the human antibody repertoire
@nl
type
label
Stability engineering of the human antibody repertoire
@ast
Stability engineering of the human antibody repertoire
@en
Stability engineering of the human antibody repertoire
@nl
prefLabel
Stability engineering of the human antibody repertoire
@ast
Stability engineering of the human antibody repertoire
@en
Stability engineering of the human antibody repertoire
@nl
P2860
P3181
P1433
P1476
Stability engineering of the human antibody repertoire
@en
P2093
David Lowe
P2860
P304
P3181
P356
10.1016/J.FEBSLET.2013.11.029
P407
P577
2014-01-21T00:00:00Z